--- title: Sinocompound expands range with new advanced high-quality Buchwald ligands and precatalysts description: Sinocompound has announced new additions to its established range of high-quality Buchwald ligands and precatalysts providing customers with even greater choice of ligands to meet their cross-coupling needs. image: https://news.lifesciencenewswire.com/hubfs/BIS0443_Sinocompound_SM_Image_V1.1-02.jpg --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (34)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (20)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (15)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (244)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (9)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (108)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (283)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Drug Discovery & Development (147)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (55)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (132)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (6)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (25)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (86)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (114)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (4)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (5)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates - ##### SHARE - - - # [Sinocompound expands range with new advanced high-quality Buchwald ligands and precatalysts](https://news.lifesciencenewswire.com/newsroom/sinocompound-expands-range-with-new-advanced-high-quality-buchwald-ligands-and-precatalysts) April 22, 2021 ![BIS0443_Sinocompound_SM_Image_V1.1-02](https://news.lifesciencenewswire.com/hs-fs/hubfs/BIS0443_Sinocompound_SM_Image_V1.1-02.jpg?width=258&name=BIS0443_Sinocompound_SM_Image_V1.1-02.jpg)Sinocompound Catalysts Co., Ltd has added to its established range of Buchwald ligands and precatalysts providing customers with even greater choice of ligands to meet their cross-coupling needs. Sinocompound is a specialist global provider of advanced homogeneous catalysts and ligands for pharmaceutical and fine chemical applications. The latest additions to the Sinocompound Buchwald range include AdCyBrettPhos (CAS 2197989-24-3), AlPhos (CAS 1805783-60-1), EPhos Pd G4 (CAS 2132978-44-8), EPhos (CAS 2118959-55-8), AdBrettPhos (CAS 1160861-59-5), and AdBrettPhos Pd G3 (CAS 1445972-29-1). Buchwald ligands are electron-rich dialkylbiaryl phosphines that are used to improve chemical reactivity in palladium catalysis. Even minor structural changes to Buchwald ligands can dramatically affect their catalytic activity in cross-coupling reactions with different substrates, which has led to the development of numerous ligands tailored for use in specific reactions. Buchwald ligands play an important role in the synthesis of pharmaceuticals, agrochemicals and organic electronic materials. Sinocompound has been manufacturing high quality Buchwald ligands and precatalysts under license from MIT since 2012 and has continued to expand the product range by adding more advanced ligands to the family. While some Buchwald ligands are currently manufactured at a relatively small scale (grams), others are routinely manufactured at a larger scale (hundreds of kilograms). With the opening of a new manufacturing plant in Tongling, Anhui Province, China, in the fourth quarter of 2021, Sinocompound is well placed to scale up production of Buchwald ligands to the meet the demands of customers. Carin Seechurn, Technical Advisor said, “At Sinocompound, we’re always looking to build out our product ranges with the ligands our customers need for their specialist applications. Our new manufacturing facility combined with a flexible approach, advanced technology and in-house expertise, mean we can not only achieve short lead times but we can also rapidly scale up production as required to fulfil individual orders.” To learn more about the full range of Buchwald ligands and precatalysts from Sinocompound, visit [http://en.sinocompound.com/product/21/](http://en.sinocompound.com/product/21/) For more information about Sinocompound, please visit [en.sinocompound.com](http://en.www.sinocompound.com/) About Sinocompound Sinocompound Catalysts Co., Ltd. is a global provider of advanced homogeneous catalysts and ligands for a range of pharmaceutical and fine chemical applications. The company’s proven process is built around cutting-edge technology, flexibility, and speed-of-response ensuring delivery at the scale required. Established partnerships across industry and academia enable the development of novel chemistry; helping customers accelerate their route to market. Established in 2008 and with headquarters in Zhangjiagang, China, Sinocompound focuses on listening to customers and delivering the high-quality catalyst technology they require – including homo- and heterogeneous metal catalysts, ligands, high-purity electronic and custom synthesis service. [en.sinocompound.com](http://en.www.sinocompound.com/) Categories: [Analytical Chemistry](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma) ##### Browse more news ## Recent releases #### [Enhanced Compliance Inc. (ECI) Appoints Taranjit S. Samra as Head of Medical Device Software Enginee...](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) July 6, 2026 Strengthens ECI’s AI & Digital Transformation capabilities to help clients develop the next generation of software-enabled medical technologies En... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomic...](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) #### [Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) June 16, 2026 Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)